The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
The fragile x mental retardation protein binds and regulates a novel class of mRNAs containing u rich target sequences
Abstract
Fragile X syndrome is a common form of inherited mental retardation caused by the absence of the fragile X mental retardation protein (FMRP). It has been hypothesized that FMRP is involved in the processing and/or translation of mRNAs. Human and mouse target-mRNAs, containing purine quartets, have previously been identified. By using cDNA-SELEX (systematic evolution of ligands by exponential enrichment), we identified another class of human target-mRNAs which contain U rich sequences. This technique, in contrast to oligonucleotide-based SELEX, allows the identification of FMRP targets directly from mRNA pools. Many of the proteins encoded by the identified FMRP targets have been implicated in neuroplasticity. Steady state levels of target-mRNAs were unchanged in the brain of fragile X mice. However, levels of two target-encoded proteins, an L-type calcium channel subunit and MAP1B, were downregulated in specific brain regions suggesting a defect in the expression of target-encoded proteins in fragile X syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
FMRP regulates stability, subcellular transport, and translation of neuronal mRNAs encoding proteins involved in synaptic structure and function.
“FMRP regulates stability, subcellular transport, and translation of neuronal mRNAs encoding for proteins involved the in synaptic structure and function (58,(65)(66)(67).”
From Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics (2012) · cites this paper as [66]
Citations
Cites
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
Absence of expression of the FMR-1 gene in fragile X syndrome
Pieretti, M., Zhang, F., Fu, Y.-H., Warren, S. T., Oostra, B. A., Caskey, C. T., & Nelson, D. L. (1991) · Cell · doi:10.1016/0092-8674(91)90125-i · Cited by 1,476
Monovalent cation-induced structure of telomeric DNA: The G-quartet model
Williamson, J. R., Raghuraman, M. K., & Cech, T. R. (1989) · Cell · doi:10.1016/0092-8674(89)90610-7 · Cited by 1,228
Brown, V., Jin, P., Ceman, S., Darnell, J. C., O'Donnell, W. T., Tenenbaum, S. A., Jin, X., Feng, Y., Wilkinson, K. D., Keene, J. D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00568-2 · Cited by 1,109
Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits
Comery, T. A., Harris, J. B., Willems, P. J., Oostra, B. A., Irwin, S. A., Weiler, I. J., & Greenough, W. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5401 · Cited by 1,046
Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function
Darnell, J. C., Jensen, K. B., Jin, P., Brown, V., Warren, S. T., & Darnell, R. B. (2001) · Cell · doi:10.1016/s0092-8674(01)00566-9 · Cited by 952
Interspersed repeats and other mementos of transposable elements in mammalian genomes
Smit, A. F. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00031-3 · Cited by 949
Hell, J. W., Westenbroek, R. E., Warner, C., Ahlijanian, M. K., Prystay, W., Gilbert, M., Snutch, T. P., & Catterall, W. A. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.123.4.949 · Cited by 760
FMR1 Protein: Conserved RNP Family Domains and Selective RNA Binding
Ashley, C. T., Wilkinson, K. D., Reines, D., & Warren, S. T. (1993) · Science · doi:10.1126/science.7692601 · Cited by 752
DNA methylation represses FMR-1 transcription in fragile X syndrome
Sutcliffe, J. S., Nelson, D. L., Zhang, F., Pieretti, M., Caskey, C. T., Saxe, D., & Warren, S. T. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.6.397 · Cited by 680
Zalfa, F., Giorgi, M., Primerano, B., Moro, A., Di Penta, A., Reis, S., Oostra, B., & Bagni, C. (2003) · Cell · doi:10.1016/s0092-8674(03)00079-5 · Cited by 676
Zhang, Y., Bailey, A. M., Matthies, H. J. G., Renden, R., Smith, M. A., Speese, S. D., Rubin, G. M., & Broadie, K. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00589-x · Cited by 651
Evidence that fragile X mental retardation protein is a negative regulator of translation
Laggerbauer, B. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.4.329 · Cited by 571
Abnormal Development of Dendritic Spines in FMR1 Knock-Out Mice
Nimchinsky, E. A., Oberlander, A. M., & Svoboda, K. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05139.2001 · Cited by 560
Feng, Y., Gutekunst, C.-A., Eberhart, D. E., Yi, H., Warren, S. T., & Hersch, S. M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-05-01539.1997 · Cited by 532
Analysis of neocortex in three males with the Fragile X syndrome
Hinton, V. J., Brown, W. T., Wisniewski, K., & Rudelli, R. D. (1991) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320410306 · Cited by 527
RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice
Miyashiro, K. Y., Beckel-Mitchener, A., Purk, T. P., Becker, K. G., Barret, T., Liu, L., Carbonetto, S., Weiler, I. J., Greenough, W. T., & Eberwine, J. (2003) · Neuron · doi:10.1016/s0896-6273(03)00034-5 · Cited by 495
The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif
Schaeffer, C., Bardoni, B., Mandel, J., Ehresmann, B., Ehresmann, C., & Moine, H. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4803 · Cited by 471
The fragile X mental retardation protein inhibits translation via interacting with mRNA
Li, Z. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.11.2276 · Cited by 448
L-type voltage-sensitive calcium channels mediate synaptic activation of immediate early genes
Murphy, T. H., Worley, P. F., & Baraban, J. M. (1991) · Neuron · doi:10.1016/0896-6273(91)90375-a · Cited by 423
Microtubule organization and dynamics dependent on microtubule-associated proteins
Hirokawa, N. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90119-8 · Cited by 414
Eberhart, D. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.8.1083 · Cited by 390
Schenck, A., Bardoni, B., Moro, A., Bagni, C., & Mandel, J.-L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151231598 · Cited by 356
The fragile X mental retardation protein is associated with ribosomes
Khandjian, E. W., Corbin, F., Woerly, S., & Rousseau, F. (1996) · Nature Genetics · doi:10.1038/ng0196-91 · Cited by 251
Meixner, A., Haverkamp, S., Wässle, H., Pangratz-Fuehrer, S., Thalhammer, J. G., Kropf, N., Bittner, R. E., Lassmann, H., Wiche, G., & Propst, F. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.6.1169 · Cited by 208
Brown, V., Small, K. M., Lakkis, L., Feng, Y., Gunter, C., Wilkinson, K. D., & Warren, S. T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15521 · Cited by 192
Ceman, S., Brown, V., & Warren, S. T. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.7925 · Cited by 181
Neuronal abnormalities in microtubule-associated protein 1B mutant mice.
Edelmann, W., Zervas, M., Costello, P. S., Roback, L., Fischer, I., Hammarback, J. A., Cowan, N. J., Davies, P., Wainer, B. H., & Kucherlapati, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1270 · Cited by 149
Trelogan, S., & Martin, S. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1520 · Cited by 144
Bardoni, B., Schenck, A., & Louis Mandel, J. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.13.2557 · Cited by 136
A nuclear role for the Fragile X mental retardation protein.
Fridell, R. A., Benson, R. E., Hua, J., Bogerd, H. P., & Cullen, B. R. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00924.x · Cited by 131
Takei, Y., Kondo, S., Harada, A., Inomata, S., Noda, T., & Hirokawa, N. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.7.1615 · Cited by 123
Dobbelstein, M., & Shenk, T. E. (1995) · Journal of Virology · doi:10.1128/jvi.69.12.8027-8034.1995 · Cited by 96
Christiansen, J., Kofod, M., & Nielsen, F. C. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.25.5709 · Cited by 85
RNAs That Interact with the Fragile X Syndrome RNA Binding Protein FMRP
Sung, Y. J., Conti, J., Currie, J. R., Brown, W. T., & Denman, R. B. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3405 · Cited by 82
Identification of Mouse YB1/p50 as a Component of the FMRP-Associated mRNP Particle
Ceman, S., Nelson, R., & Warren, S. T. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4035 · Cited by 81
Nitrocellulose Filter Binding for Determination of Dissociation Constants
Hall, K. B., & Kranz, J. K. (2003) · Humana Press eBooks · doi:10.1385/1-59259-676-2:105 · Cited by 40
Composite of A and F-type 5′ terminal sequences defines a subfamily of mouse LINE-1 elements
Adey, N. B., Schichman, S. A., Hutchison, C. A., & Edgell, M. H. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)80057-2 · Cited by 19
Irwin (2001) · doi:10.1002/1096-8628(20010115)98:2
Flagged first, then by citations
1 of the 40 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
John, B., Enright, A. J., Aravin, A., Tuschl, T., Sander, C., & Marks, D. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020363 · Cited by 3,796
The mGluR theory of fragile X mental retardation
Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580
SELEX—A (r)evolutionary method to generate high-affinity nucleic acid ligands
Stoltenburg, R., Reinemann, C., & Strehlitz, B. (2007) · Biomolecular Engineering · doi:10.1016/j.bioeng.2007.06.001 · Cited by 1,485
Molecular Mechanisms of Fragile X Syndrome: A Twenty-Year Perspective
Santoro, M. R., Bray, S. M., & Warren, S. T. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132457 · Cited by 528
Small regulatory RNAs in mammals
Mattick, J. S., & Makunin, I. V. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi101 · Cited by 521
Hou, L., Antion, M. D., Hu, D., Spencer, C. M., Paylor, R., & Klann, E. (2006) · Neuron · doi:10.1016/j.neuron.2006.07.005 · Cited by 469
From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome
Bagni, C., & Greenough, W. T. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1667 · Cited by 475
Altered Neuronal and Circuit Excitability in Fragile X Syndrome
Contractor, A., Klyachko, V. A., & Portera‐Cailliau, C. (2015) · Neuron · doi:10.1016/j.neuron.2015.06.017 · Cited by 418
Local translation of RhoA regulates growth cone collapse
Wu, K. Y., Hengst, U., Cox, L. J., Macosko, E. Z., Jeromin, A., Urquhart, E. R., & Jaffrey, S. R. (2005) · Nature · doi:10.1038/nature03885 · Cited by 423
The Pathophysiology of Fragile X Syndrome
Penagarikano, O., Mulle, J. G., & Warren, S. T. (2007) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.8.080706.092249 · Cited by 420
The Pathophysiology of Fragile X (and What It Teaches Us about Synapses)
Bhakar, A. L., Dölen, G., & Bear, M. F. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153138 · Cited by 370
A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability
Zalfa, F., Eleuteri, B., Dickson, K. S., Mercaldo, V., Rubeis, S. D., di Penta, A., Tabolacci, E., Chiurazzi, P., Neri, G., Grant, S. G. N., et al. (2007) · Nature Neuroscience · doi:10.1038/nn1893 · Cited by 370
Altered anxiety‐related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome
Spencer, C. M., Alekseyenko, O., Serysheva, E., Yuva‐Paylor, L. A., & Paylor, R. (2005) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2005.00123.x · Cited by 349
Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics
Bagni, C., Tassone, F., Neri, G., & Hagerman, R. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63141 · Cited by 321
A synaptic perspective of fragile X syndrome and autism spectrum Disorders.
Bagni, C., & Zukin, R. S. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.041 · Cited by 326
FMRP Mediates mGluR5-Dependent Translation of Amyloid Precursor Protein
Westmark, C. J., & Malter, J. S. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050052 · Cited by 296
“]. In addition, FMRP binds to uridine-rich mRNAs [”
BackgroundHepatitis C Virus Nonstructural Protein 5A (NS5A) Is an RNA-binding Protein
Huang, L., Hwang, J., Sharma, S. D., Hargittai, M. R. S., Chen, Y., Arnold, J. J., Raney, K. D., & Cameron, C. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508175200 · Cited by 268
Fragile X Mental Retardation Protein Regulates Translation by Binding Directly to the Ribosome
Chen, E., Sharma, M. R., Shi, X., Agrawal, R. K., & Joseph, S. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.023 · Cited by 253
Decreased GABAA receptor expression in the seizure-prone fragile X mouse
Idrissi, A. E., Ding, X., Scalia, J., Trenkner, E., Brown, W. T., & Dobkin, C. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.087 · Cited by 210
The Unstable Repeats—Three Evolving Faces of Neurological Disease
Nelson, D. L., Orr, H. T., & Warren, S. T. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.022 · Cited by 207
The G-quartet containing FMRP binding site in FMR1 mRNA is a potent exonic splicing enhancer
Didiot, M.-C., Tian, Z., Schaeffer, C., Subramanian, M., Mandel, J., & Moine, H. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn472 · Cited by 196
Meredith, R. M., Holmgren, C. D., Weidum, M., Burnashev, N., & Mansvelder, H. D. (2007) · Neuron · doi:10.1016/j.neuron.2007.04.028 · Cited by 190
Soden, M. E., & Chen, L. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3660-10.2010 · Cited by 181
Self-citationAbnormal Striatal GABA Transmission in the Mouse Model for the Fragile X Syndrome
Centonze, D., Rossi, S., Mercaldo, V., Napoli, I., Ciotti, M. T., De Chiara, V., Musella, A., Prosperetti, C., Calabresi, P., Bernardi, G., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.008 · Cited by 171
Functional and Selective RNA Interference in Developing Axons and Growth Cones
Hengst, U., Cox, L. J., Macosko, E. Z., & Jaffrey, S. R. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.5229-05.2006 · Cited by 170
Lee, H. Y., Ge, W., Huang, W. C., He, Y., Wang, G. X., Rowson-Baldwin, A., Smith, S. J., Jan, Y. N., & Jan, L. Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.033 · Cited by 153
Early developmental alterations in GABAergic protein expression in fragile X knockout mice
Adusei, D. C., Pacey, L. K. K., Chen, D., & Hampson, D. R. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.05.002 · Cited by 139
Zalfa, F., Adinolfi, S., Napoli, I., Kühn‐Hölsken, E., Urlaub, H., Achsel, T., Pastore, A., & Bagni, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504286200 · Cited by 141
Species-dependent posttranscriptional regulation of NOS1 by FMRP in the developing cerebral cortex
Kwan, K. Y., Lam, M. M. S., Johnson, M. B., Dube, U., Shim, S., Rašin, M.-R., Sousa, A. M. M., Fertuzinhos, S., Chen, J.-G., Arellano, J. I., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.060 · Cited by 137
Tucker, B., Richards, R. I., & Lardelli, M. T. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl422 · Cited by 133
FMRP RNA targets: identification and validation
Darnell, J. C., Mostovetsky, O., & Darnell, R. B. (2005) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2005.00144.x · Cited by 132
Fragile X syndrome: from molecular genetics to therapy
D’Hulst, C., & Kooy, R. F. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.064667 · Cited by 128
Post-transcriptional operons and regulons co-ordinating gene expression
Keene, J. D., & Lager, P. J. (2005) · Chromosome Research · doi:10.1007/s10577-005-0848-1 · Cited by 124
Saldarriaga, W., Tassone, F., González-Teshima, L. Y., Forero-Forero, J. V., Ayala‐Zapata, S., & Hagerman, R. J. (2014) · Colombia medica · doi:10.25100/cm.v45i4.1810 · Cited by 126
A metabolomic and systems biology perspective on the brain of the fragile X syndrome mouse model
Davidovic, L., Navratil, V., Bonaccorso, C. M., Catania, M. V., Bardoni, B., & Dumas, M.-E. (2011) · Genome Research · doi:10.1101/gr.116764.110 · Cited by 118
MOV10 and FMRP Regulate AGO2 Association with MicroRNA Recognition Elements
Kenny, P., Zhou, H., Kim, M., Skariah, G., Khetani, R. S., Drnevich, J. M., Arcila, M. L., Kosik, K. S., & Ceman, S. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.054 · Cited by 121
Multifarious Functions of the Fragile X Mental Retardation Protein
Davis, J. K., & Broadie, K. S. (2017) · Trends in Genetics · doi:10.1016/j.tig.2017.07.008 · Cited by 118
Spencer, C. M., Serysheva, E., Yuva‐Paylor, L. A., Oostra, B. A., Nelson, D. L., & Paylor, R. E. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl121 · Cited by 123
Ramos, A., Hollingworth, D., Adinolfi, S., Castets, M., Kelly, G. P., Frenkiel, T. A., Bardoni, B., & Pastore, A. (2006) · Structure · doi:10.1016/j.str.2005.09.018 · Cited by 115
Zhang, Z., Marro, S. G., Zhang, Y., Arendt, K. L., Patzke, C., Zhou, B., Fair, T., Yang, N., Südhof, T. C., Wernig, M., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar4338 · Cited by 110
Self-citationThe FMRP regulon: from targets to disease convergence
Fernández, E., Rajan, N., & Bagni, C. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00191 · Cited by 117
Saldarriaga, W., Tassone, F., González-Teshima, L. Y., Forero-Forero, J. V., Ayala‐Zapata, S., & Hagerman, R. J. (2014) · Europe PMC (PubMed Central) · Cited by 109
Garnon, J., Lachance, C., Marco, S. D., Hel, Z., Marion, D., Ruiz, M. C., Newkirk, M. M., Khandjian, É. W., & Radzioch, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401988200 · Cited by 106
Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back
Gross, C., Hoffmann, A., Bassell, G. J., & Berry-Kravis, E. M. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0355-9 · Cited by 105
Channelopathies in fragile X syndrome
Deng, P., & Klyachko, V. A. (2021) · Nature reviews. Neuroscience · doi:10.1038/s41583-021-00445-9 · Cited by 112
Targeted treatments for fragile X syndrome
Berry‐Kravis, E., Knox, A. T., & Hervey, C. (2011) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-011-9074-7 · Cited by 108
Fragile X syndrome: From protein function to therapy
Bagni, C., & Oostra, B. A. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36241 · Cited by 110
Deregulated mTOR-mediated translation in intellectual disability
Troca-Marín, J. A., Alves-Sampaio, A., & Montesinos, M. L. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.01.005 · Cited by 109
Aloisi, E., Corf, K. L., Dupuis, J. P., Zhang, P., Ginger, M. R., Labrousse, V. F., Spatuzza, M., Haberl, M. G., Costa, L., Shigemoto, R., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01191-2 · Cited by 98
The fragile X syndrome: exploring its molecular basis and seeking a treatment
Bardoni, B., Davidovic, L., Bensaid, M., & Khandjian, É. W. (2006) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399406010751 · Cited by 106
Pilpel, Y., Kolleker, A., Berberich, S., Ginger, M., Frick, A., Mientjes, E., Oostra, B. A., & Seeburg, P. H. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2008.160929 · Cited by 102
Piazzon, N., Rage, F., Schlotter, F., Moine, H., Branlant, C., & Massenet, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707304200 · Cited by 107
The GABAAreceptor is an FMRP target with therapeutic potential in fragile X syndrome
Braat, S., D’Hulst, C., Heulens, I., Rubeis, S. D., Mientjes, E., Nelson, D. L., Willemsen, R., Bagni, C., Dam, D. V., Deyn, P. P. D., et al. (2015) · Cell Cycle · doi:10.4161/15384101.2014.989114 · Cited by 98
Arginine methylation of RNA‐binding proteins regulates cell function and differentiation
Blackwell, E., & Ceman, S. (2011) · Molecular Reproduction and Development · doi:10.1002/mrd.22024 · Cited by 95
Moon, J., Beaudin, A. E., Verosky, S. C., Driscoll, L. L., Weiskopf, M., Levitsky, D. A., Crnic, L. S., & Strupp, B. J. (2006) · Behavioral Neuroscience · doi:10.1037/0735-7044.120.6.1367 · Cited by 91
Fatemi, S. H., & Folsom, T. D. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.10.010 · Cited by 86
Disordered RNA chaperone proteins: from functions to disease
Iványi-Nagy, R., Davidovic, L., Khandjian, E. W., & Darlix, J. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5100-9 · Cited by 82
Mazrouï, R. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg335 · Cited by 82
A structural perspective of RNA recognition by intrinsically disordered proteins
Basu, S., & Bahadur, R. P. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2283-1 · Cited by 82
Suhl, J. A., Chopra, P., Anderson, B. R., Bassell, G. J., & Warren, S. T. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu272 · Cited by 81
Differential translation and fragile X syndrome
Vanderklish, P. W., & Edelman, G. M. (2005) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2005.00134.x · Cited by 59
Function and translational regulation of mRNA in developing axons
Hengst, U., & Jaffrey, S. R. (2007) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2007.01.003 · Cited by 81
The fragile X mental retardation protein has nucleic acid chaperone properties
Gabus, C. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh535 · Cited by 74
Fatimy, R. E., Tremblay, S., Dury, A. Y., Solomon, S., Koninck, P. D., Schrader, J. W., & Khandjian, É. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039338 · Cited by 73
Modeling Fragile X Syndrome in Drosophila
Drozd, M. M., Bardoni, B., & Capovilla, M. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00124 · Cited by 70
Fathoming fragile X in fruit flies
Zhang, Y., & Broadie, K. S. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.11.003 · Cited by 66
Zhang, Y., Friedman, D. B., Wang, Z., Woodruff, E. A., Pan, L., O’Donnell, J. M., & Broadie, K. S. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400174-mcp200 · Cited by 65
Channelopathies and dendritic dysfunction in fragile X syndrome
Brager, D. H., & Johnston, D. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2014.01.002 · Cited by 65
Identification of consensus binding sites clarifies FMRP binding determinants
Anderson, B. R., Chopra, P., Suhl, J. A., Warren, S. T., & Bassell, G. J. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw593 · Cited by 68
Bechara, E., Davidovic, L., Melko, M., Bensaid, M., Tremblay, S., Grosgeorge, J., Khandjian, E. W., Lalli, E., & Bardoni, B. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl1021 · Cited by 59
FMR1 and Autism, an Intriguing Connection Revisited
Fyke, W., & Velinov, M. T. (2021) · Genes · doi:10.3390/genes12081218 · Cited by 60
Fragile X Screening by Quantification of FMRP in Dried Blood Spots by a Luminex Immunoassay
LaFauci, G., Adayev, T., Kascsak, R. J., Kascsak, R., Nolin, S. L., Mehta, P. D., Brown, W. T., & Dobkin, C. (2013) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.02.006 · Cited by 56
Hyperexcitability and homeostasis in fragile X Syndrome.
Liu, X., Kumar, V., Tsai, N.-P., & Auerbach, B. D. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.805929 · Cited by 53
RNA-binding proteins as molecular links between cancer and neurodegeneration
Campos‐Melo, D., Droppelmann, C. A., Volkening, K., & Strong, M. J. (2014) · Biogerontology · doi:10.1007/s10522-014-9531-2 · Cited by 51
COPI transport complexes bind to specific RNAs in neuronal cells
Todd, A. G., Lin, H., Ebert, A. D., Liu, Y., & Androphy, E. J. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds480 · Cited by 50
Sosińska, P., Mikuła‐Pietrasik, J., & Książek, K. (2015) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2015.08.002 · Cited by 42
Suhl, J. A., & Warren, S. T. (2015) · Journal of Experimental Neuroscience · doi:10.4137/jen.s25524 · Cited by 43
Suzuki, T., Tian, Q. B., Kuromitsu, J., Kawai, T., & Endo, S. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.09.009 · Cited by 41
Schaefer, T. L., Davenport, M. H., Grainger, L. M., Robinson, C. K., Earnheart, A. T., Stegman, M., Lang, A. L., Ashworth, A. A., Molinaro, G., Huber, K. M., et al. (2017) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-017-9184-y · Cited by 38
Doll, C. A., & Broadie, K. S. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.02.006 · Cited by 39
The Fragile X Mental Retardation Protein in Circadian Rhythmicity and Memory Consolidation
Gatto, C. L., & Broadie, K. S. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8057-0 · Cited by 38
A Comparative Perspective on Wnt/β-Catenin Signalling in Cell Fate Determination
Garcin, C. L., & Habib, S. J. (2017) · Results and problems in cell differentiation · doi:10.1007/978-3-319-53150-2_15 · Cited by 40
Fragile X Syndrome and Alzheimers Disease: Another Story About APP and β -Amyloid
Malter, J. S., Ray, B. C., Westmark, P. R., & Westmark, C. J. (2010) · Current Alzheimer Research · doi:10.2174/156720510791050957 · Cited by 34
Dysregulated Prefrontal Cortex Inhibition in Prepubescent and Adolescent Fragile X Mouse Model
Kramvis, I., van Westen, R., Lammertse, H. C. A., Riga, D., Heistek, T. S., Loebel, A., Spijker, S., Mansvelder, H. D., & Meredith, R. M. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00088 · Cited by 34
FMRP regulates actin filament organization via the armadillo protein p0071
Nolze, A., Schneider, J., Keil, R., Lederer, M., Hüttelmaier, S., Kessels, M. M., Qualmann, B., & Hatzfeld, M. (2013) · RNA · doi:10.1261/rna.037945.112 · Cited by 35
Jeon, S. J., Seo, J. E., Yang, S., Choi, J. W., Wells, D. G., Shin, C. Y., & Ko, K. H. (2011) · Journal of Biomedical Science · doi:10.1186/1423-0127-18-17 · Cited by 32
Matić, K., Eninger, T., Bardoni, B., Davidovic, L., & Maček, B. (2014) · Journal of Proteome Research · doi:10.1021/pr5006372 · Cited by 33
Differential regulation of BK channels by fragile X mental retardation protein
Kshatri, A. S., Cerrada, A., Gimeno, R., Bartolomé‐Martín, D., Rojas, P., & Giráldez, T. (2020) · The Journal of General Physiology · doi:10.1085/jgp.201912502 · Cited by 31
Gatto, C. L., & Broadie, K. S. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2011.05.001 · Cited by 32
Rousseau, F., Labelle, Y., Bussières, J., & Lindsay, C. (2011) · Europe PMC (PubMed Central) · Cited by 30
Molecular and Genetic Analysis of the Drosophila Model of Fragile X Syndrome
Tessier, C. R., & Broadie, K. S. (2011) · Results and problems in cell differentiation · doi:10.1007/978-3-642-21649-7_7 · Cited by 31
Fragile X syndrome: from gene discovery to therapy
Heulens, I. (2010) · Frontiers in bioscience · doi:10.2741/3785 · Cited by 32
Downregulation of GABAA β Subunits is Transcriptionally Controlled by Fmr1p
Hong, A., Zhang, A., Ke, Y., Idrissi, A. E., & Shen, C.-H. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9531-5 · Cited by 30
Modelling fragile X syndrome in the laboratory setting: A behavioral perspective
Melancia, F., & Trezza, V. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.04.042 · Cited by 31
New Insights Into the Role of Cav2 Protein Family in Calcium Flux Deregulation in Fmr1-KO Neurons
Castagnola, S., Delhaye, S., Folci, A., Paquet, A. C., Brau, F., Duprat, F., Jarjat, M., Grossi, M., Béal, M., Martin, S., et al. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00342 · Cited by 30
Ohashi, R., & Shiina, N. (2020) · Biomolecules · doi:10.3390/biom10020167 · Cited by 33
FMRP-Driven Neuropathology in Autistic Spectrum Disorder and Alzheimer's disease: A Losing Game
Bleuzé, L., Triaca, V., & Borreca, A. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.699613 · Cited by 28
Lee, H. Y., & Jan, L. Y. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2012.03.010 · Cited by 25
Abdelsayed, M. M., Ho, B. T., Vu, M., Polanco, J. A., Spitale, R. C., & Lupták, A. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00001 · Cited by 25
Structural transitions in poly(A), poly(C), poly(U), and poly(G) and their possible biological roles
Zarudnaya, M. I., Kolomiets, I. N., Potyahaylo, A. L., & Hovorun, D. М. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1503972 · Cited by 24
Metadata
- Authors
- Chen, L., Yun, S.-W., Seto, J., Liu, W., & Toth, M.
- Affiliations
- Cornell University (US)
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 2003-09
- Volume
- 120
- Issue
- 4
- Pages
- 1005-1017
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W2038651628
- Cited by
- 160
- References
- 40
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 8 · 2020: 7 · 2019: 3 · 2018: 6 · 2017: 11 · 2016: 8 · 2015: 7 · 2014: 12 · 2013: 5 · 2012: 13
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ns034151-06)
- National Institute of Neurological Disorders and Stroke (R01NS34151)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Keywords
- fragile X syndrome, FMRP, mRNA binding, U-rich sequences, MAP1B, neuroplasticity, brain gene expression
- MeSH terms
- Adenosine Triphosphatases, Animals, Bacteria, Base Sequence, Brain, Cell Line, Clathrin, Dose-Response Relationship, Drug, Embryo, Mammalian, Embryo, Nonmammalian, Fetus, Humans, Insecta, Kidney, Microtubule-Associated Proteins, Molecular Sequence Data, Mucins, Nerve Tissue Proteins, Oligopeptides, Peptides, Phosphopyruvate Hydratase, Protein Binding, RNA, Messenger, Uridine, Blotting, Western, RNA-Binding Proteins, Sequence Homology, Amino Acid, Mice, Knockout, Reverse Transcriptase Polymerase Chain Reaction, Guanine Nucleotide Dissociation Inhibitors, rhoA GTP-Binding Protein, Electrophoretic Mobility Shift Assay, RNA-Binding Protein FUS, Mice, Fragile X Messenger Ribonucleoprotein 1, Fragile X Mental Retardation Protein, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review